search button
Open Access

Clinical outcomes in primary scalp angiosarcoma

Corrigendum in: /10.3892/ol.2020.12025

  • Authors:
    • Yong Zhang
    • Yanwen Yan
    • Ming Zhu
    • Cheng Chen
    • Nanhang Lu
    • Fazhi Qi
    • Jiaqi Liu

  • View Affiliations

  • Published online on: September 19, 2019     https://doi.org/10.3892/ol.2019.10886
  • Pages: 5091-5096

  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Scalp angiosarcoma is a rare, extremely aggressive cutaneous malignancy with poor patient prognosis. The present study reviewed the cases of 42 patients who presented scalp angiosarcoma and were treated at the Zhongshan Hospital of Fudan University between January 2002 and December 2013. The clinical characteristics, demographics, treatment regimens and outcomes of patients were analyzed, and the overall survival (OS) and recurrence‑free survival (RFS) rates were calculated. A total of 42 patients were examined in this study. Surgery was the most common therapeutic measure, and was performed in 39 patients, alone (12 patients), in combination with chemotherapy (14 patients), radiotherapy (6 patients) or 3‑modality‑therapy (7 patients). The median follow‑up time of patients was 28.5 months. The 5‑year OS rate was 19%, and the 5‑year RFS rate was 10%. Taken together, the results of the present study suggested that patients whose tumor presented a nodular localized lesion had a significantly improved OS rate (P=0.0078). Patients aged ≥70 years were associated with a lower 5‑year OS (P=0.0071) and RFS rates (P=0.0095) vs. patients aged <70 years. Different treatments were not identified to be significantly associated with an improved OS or RFS. The present results also indicated that if the tumor presented nodular localized lesions, the patients exhibited a better prognosis than those with a diffuse lesion. Although younger patients had better clinical outcomes, the likelihood of recurrence and mortality remained high for all patients.
View Figures
View References

Related Articles

Journal Cover

November-2019
Volume 18 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.9
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 6.3
  • CiteScore Rank: Q2: #119/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.725
  • SCImago Journal Rank (SJR): 0.639
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Y, Yan Y, Zhu M, Chen C, Lu N, Qi F and Liu J: Clinical outcomes in primary scalp angiosarcoma Corrigendum in /10.3892/ol.2020.12025. Oncol Lett 18: 5091-5096, 2019
APA
Zhang, Y., Yan, Y., Zhu, M., Chen, C., Lu, N., Qi, F., & Liu, J. (2019). Clinical outcomes in primary scalp angiosarcoma Corrigendum in /10.3892/ol.2020.12025. Oncology Letters, 18, 5091-5096. https://doi.org/10.3892/ol.2019.10886
MLA
Zhang, Y., Yan, Y., Zhu, M., Chen, C., Lu, N., Qi, F., Liu, J."Clinical outcomes in primary scalp angiosarcoma Corrigendum in /10.3892/ol.2020.12025". Oncology Letters 18.5 (2019): 5091-5096.
Chicago
Zhang, Y., Yan, Y., Zhu, M., Chen, C., Lu, N., Qi, F., Liu, J."Clinical outcomes in primary scalp angiosarcoma Corrigendum in /10.3892/ol.2020.12025". Oncology Letters 18, no. 5 (2019): 5091-5096. https://doi.org/10.3892/ol.2019.10886